31
Sharing and Open Knowledge and the Future of Scientific Research Hiroaki Kitano The Systems Biology Institute Sony Computer Science Laboratories, Inc.

Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Sharing and Open Knowledge and the Future of Scientific

ResearchHiroaki Kitano

The Systems Biology Institute

Sony Computer Science Laboratories, Inc.

Page 2: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano
Page 3: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

EGF Receptor Cascade

Oda, et al. Molecular Systems Biology, 2005

Page 4: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Architectural Feature

Kitano, Nature Reviews Genetics, Nov. 2004

Page 5: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Copyright ©2007 by the National Academy of Sciences

Kim, Pan-Jun et al. (2007) Proc. Natl. Acad. Sci. USA 104, 13638-13642

Fig. 1. Characteristics of essential and nonessential metabolites in E. coli metabolism

Page 6: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Ma et al, Molecular Systems Biology, Sept 2007

Page 7: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Bow-Tie Architecture of Wikipedia links

Capocci, et al., Phys Rev. E 74, 036116, 2006

Page 8: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

EGF Receptor Cascade

Oda, et al. Molecular Systems Biology, 2005

Page 9: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Oda, et al. Molecular Systems Biology, 2005

Page 10: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano
Page 11: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

TLR Bow-Tie Structure

Oda and Kitano, Molecular Systems Biology, April 2006

Page 12: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

低下する製薬産業の生産性

Page 13: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Copyright ©2003 by the National Academy of Sciences

Borisy, Alexis A. et al. (2003) Proc. Natl. Acad. Sci. USA 100, 7977-7982

Multicomponent therapeutics that prevent proliferation of fluconazole-resistant C. albicans

CombinatoRX (CRXX: NASDAQ) cHTS

Page 14: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Copyright ©2003 by the National Academy of Sciences

Borisy, Alexis A. et al. (2003) Proc. Natl. Acad. Sci. USA 100, 7977-7982

Chlorpromazine, an antipsychotic agent, and pentamidine, an antiprotozoal agent, together selectively prevent tumor cell growth in vitro and in vivo

Phase 1/2A Stage

Page 15: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Copyright ©2003 by the National Academy of Sciences

Borisy, Alexis A. et al. (2003) Proc. Natl. Acad. Sci. USA 100, 7977-7982

Chlorpromazine, an antipsychotic agent, and pentamidine, an antiprotozoal agent, together selectively prevent tumor cell growth in vitro and in vivo

Phase 1/2A Stage

Efficacy

Page 16: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano
Page 17: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

朝鮮人参の成分分析

Wang, M. et al., Phytother Res. 2005 Mar;19(3):173-82

Page 18: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Open Pharma• Combination of Generic compounds to

generate highly effective drugs• Equivalent efficacy by partial replacement

of compounds• Value lies in “Combination” rather than

compound itself.

• Toward open source pharmaceutical industry

The Rule of the Game Will Change

Page 19: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

“PAYAO”Web 2.0 Community Tagging System

to SBML models

Okinawa Institute of Science and TechnologyThe Systems Biology Institute

Page 20: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

“PAYAO”

• an artificial floating raft where fish congregate

Page 21: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Payao: Web2.0 Community-Based Biological Knowledge Accumulation System

Page 22: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

SBML Models Tagging System

*CellDesigner files

PAYAOSBML Models Tagging System

Manage Models,

Users,Groups

SBML files

Register a model

Store models, Tags, Comments

Login Users

VisitorsModel OwnerAdd Comments

Add/Edit Tags

to the model

View Models withCellDesigner notation

Group A

Group B

Page 23: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Model View

Page 24: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Model View with Tag Marks

Page 25: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Tag

Page 26: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

View a Tag

Page 27: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Add Comments to a Tag

Page 28: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

View Comments to a Tag

Page 29: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

PubMed ID Link

Page 30: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Healthcare & Wellness ConciergeGenome Diagnosis(23 and me)

Wellness(India, etc)

Personalized & Preventive medicine

How to integratemedicine and wellness?

Herbal medicine, meditation, etc.

Novel Drug Design and Integrated Healthcare Support

Page 31: Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Summary

• Networks are complex but has sort of “design principles”

• Long tail drug need to be pursued to create more effective drugs

• Open Pharma may open up a whole new paradigm of drug design, distribution, and services.

• Open infrastructure is the key for success